how is hers still selling semaglutide Hims & Plan to Sell Knockoff Weight Loss Drug Looking Shaky The era of $199 copycat

Semaglutide is not taken daily for weight lossit's administered once weekly as an injection

Zepbound saw a 14% increase since 2024, leaving 4.9 million people without coverage, and Ozempic saw a 22% increase, affecting another 1.1 million people.

Citing unprecedented demand, drugmaker Novo Nordisk said Thursday it expects supply restrictions on starter doses of the weight loss medicine Wegovy to persist into 2024, several months beyond its previous prediction.

GLP-1 receptor agonists like semaglutide originally developed for diabetes and obesity also exhibit antidepressant properties, highlighting their dual therapeutic promise

Read the research:

Now Eli Lilly and Company is choosing the instead of a in Indias #obesity drug market